Ken Griffin Cytosorbents Corp Put Options Transaction History

Citadel Advisors LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$0.7 - $1.01 $350 - $505	500 New	500 $0
Q3 2023 Nov 14, 2023	BUY	$1.86 - $4.03 $558 - $1,209	300 Added 16.67%	2,100 $3,000
Q2 2023 Aug 14, 2023	SELL	$2.37 - $3.65 $17,775 - $27,375	-7,500 Reduced 80.65%	1,800 $6,000
Q1 2023 May 15, 2023	BUY	$1.79 - $4.17 $16,647 - $38,781	9,300 New	9,300 $31,000

16.7M

15.4K

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $42.3M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.